𝔖 Bobbio Scriptorium
✦   LIBER   ✦

67 Anti-hepatitis B specific β-L-2′-deoxynucleosides: ML Bryant1, G Gosselin2, RF Schinazi3, and J-L Imbach2, and J-P Sommadossi4. 1Novirio Pharmaceuticals; USA; 2Univ. de Montpellier II, France 3Emory Univ. and VA Med. Center, Decatur, GA, USA; 4University of Alabama at Birmingham, USA

Book ID
114144211
Publisher
Elsevier Science
Year
2000
Tongue
English
Weight
77 KB
Volume
46
Category
Article
ISSN
0166-3542

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

88 β-L-Thymidine and β-L-2′-deoxycytidin
88 β-L-Thymidine and β-L-2′-deoxycytidine are potent, selective and specific anti-hepatitis B virus agents: A Farai1, AG Loi2, L Cui1, MY Xie1, M Bryant2, EG Bridges2, A Juodawlkis2, C Pierra2, D Dukhan2, G Gosselin3, J-L Imbach3, RF Schinazi4, B Pai4, B Korba5, P Marion6, and J-P Sommadossi1. 1Univ. of Alabama at Birmingham, USA; 2Novirio Pharmaceuticals; 3Univ. de Montpellier II, France; 4Emory Univ. and VA Med. Center, Decatur, GA, USA; 5Georgetown Univ., Rockville, MD, USA; and 6Stanford Univ., Stanford, CA, USA
📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 114 KB
1 L-enantiomers of 2′- and 3′-azido-2′,3
1 L-enantiomers of 2′- and 3′-azido-2′,3′-dideoxy-5-fluorocytidine: Stereospecific synthesis and antiviral activity: G. Gosselin,1,2 J.-F. Griffon,2 L. Hollecker,2 J.-L. Imbach,1,2 M. Bryant,3 R.F. Schinazi,4 and J.-P. Sommadossi5. 1Laboratoire Coopératif Novirio-CNRS-Université Montpellier II; 2UMR 5625 CNRS-Université Montpellier II, France; 3Novirio Pharmaceuticals, 4Emory University and VA Med Center, Decatur, USA, and 5University of Alabama at Birmingham, USA
📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 61 KB
91 Antiviral activity of β-L-thymidine a
91 Antiviral activity of β-L-thymidine and β-L-2′-deoxycytidine in the woodchuck model of chronic hepatitis B infection: EG Bridges1, A Juodawlkis1, A Faraj2, B Tennant3, B Korba4, RF Schinazi5, T Barnett5, G Gosselin6, J-L Imbach6, C Pierra1, D Dukhan1, J-P Sommadossi2, M Bryant1. 1Novirio Pharmaceuticals; 2Univ. of Alabama at Birmingham, USA; 3Cornell Univ., Ithaca, NY; 4Georgetown Univ., Rockville, MD, USA; 5Emory Univ. and VA Med. Center, Decatur, GA, USA; 6Univ. de Montpellier II, France
📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 114 KB
Cellular pharmacology of β - L - dideoxy
Cellular pharmacology of β - L - dideoxycytidine, β - L - 2′, 3′ dideoxy - 5 - fluorocytidine, and β - D - 2′, 3′ dideoxy - 5 - fluorocytidine: L.T. Martin1, R.F. Schinazi2, G. Gosselin3, J.-L. Imbach3, and J.-P. Sommadossi1. University of Alabama at Birmingham, Birminghmn, AL 35294 USA;1 VA Medical Center/Emory University, Decatur, GA 30033 USA;2 University of Montpellier II, 34095 Montpellier, France.3
📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 88 KB
33 Selective inhibition of viral dna pol
33 Selective inhibition of viral dna polymerases by the triphosphates of β-L-2′,3′-dideoxycytidine (β-L-DDC) and its 5-fluoro derivative (β-L-FDDC): A. Faraj1, R.F. Schinazi2 G. Gosselin3,J-L Imbach,3 and J.P. Sommadossi1. 1University of Alabama at Birmingham, Birmingham, AL 35294, USA; 2VA Medical Center/ Emory University, Decatur, GA 30033, USA; and 3University of Montpellier II, 34095 Montpeller, France
📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 80 KB